Condition
Metabolic Associated Steatotic Liver Disease
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 2 (2)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07313787Phase 2Not Yet Recruiting
Effects of Meal Macronutrients on Postprandial Lipids
NCT07481734Phase 2RecruitingPrimary
Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)
NCT07122700Recruiting
Evaluation of Non-Invasive Tests for Metabolic Liver Disease
Showing all 3 trials